Results 171 to 180 of about 1,303,488 (267)
Metabolomics‐based ageing clocks developed using blood biomarkers from over 215 000 European adults, improved the prediction of 10‐year all‐cause mortality compared to traditional models. Biological age acceleration is associated with higher mortality risk, as each additional year of metabolic age corresponded to at least 8% increased risk. These tools
Lei Peng +4 more
wiley +1 more source
Higher serum UA levels are associated with reduced AD risk in epidemiological studies. UA enhances microglial phagocytic capacity primarily by restoring CD36 and TREM2 receptor recycling that is impaired by Aβ exposure. Therapeutically, UA supplementation improves cognitive function and reduces neuropathology in AD mouse model by enhancing microglial ...
De Xie +18 more
wiley +1 more source
Epidemiology of mature T-cell and NK-cell neoplasms: east and west [PDF]
Yok‐Lam Kwong +3 more
openalex +1 more source
Studies on dengue epidemiology and biological control of its vector
Faiz Ahmed Raza
openalex +1 more source
CircPROSC promotes craniosynostosis by sponging miR‐6815‐5p, thereby activating WNT3A/β‐catenin signaling and enhancing RUNX2‐mediated osteogenesis. Targeted silencing of circPROSC with MSC membrane–coated siRNA nanoparticles (MM@Lipo/si‐circPROSC) delivered postnatally into cranial sutures attenuates premature suture closure in Twist1+/– mice ...
Zhenkun Weng +6 more
wiley +1 more source
Is Digital Epidemiology the Future of Clinical Epidemiology?
Giuseppe Lippi +2 more
doaj +1 more source
Evaluating Large Language Models' Potential in Field Epidemiology Investigation Based on Chinese Context- Zhejiang Province, China, 2025. [PDF]
Zhang T +8 more
europepmc +1 more source
Epidemiology, epidemiologists, and coronavirus disease (COVID-19) - A perspective
Sudip Bhattacharya +2 more
openalex +1 more source
Elevated levels of the plasticizer DEHP associate with earlier breast cancer diagnosis. DEHP enhances glutamine‐powered energy production via the transporter SLC6A14 and pushes mitochondria toward fusion, driving tumor initiation by boosting cancer stemness. Blocking SLC6A14 lowers stemness, slows tumors, and improves chemotherapy response.
Dai‐Wei Hu +15 more
wiley +1 more source

